Literature DB >> 23389386

Thrombolysis in ischemic stroke patients on treatment with Dabigatran.

Giuseppe Re, Danilo Toni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23389386     DOI： 10.1007/s11739-013-0907-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.

Authors:  Satoru Takeuchi; Kojiro Wada; Kimihiro Nagatani; Naoki Otani; Hideo Osada; Hiroshi Nawashiro
Journal:  Acta Neurochir (Wien)       Date:  2011-10-25       Impact factor: 2.216

2.  Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

Authors:  Ignacio Casado Naranjo; Juan Carlos Portilla-Cuenca; Pedro Enrique Jiménez Caballero; Maria Luisa Calle Escobar; Raúl Mauricio Romero Sevilla
Journal:  Cerebrovasc Dis       Date:  2011-12-01       Impact factor: 2.762

3.  Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

Authors:  Ann De Smedt; Sylvie De Raedt; Koenraad Nieboer; Jacques De Keyser; Raf Brouns
Journal:  Cerebrovasc Dis       Date:  2010-09-28       Impact factor: 2.762

4.  Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.

Authors:  María C Matute; Marta Guillán; Juan García-Caldentey; Javier Buisan; María Aparicio; Jaime Masjuan; María Alonso de Leciñana
Journal:  Thromb Haemost       Date:  2011-04-20       Impact factor: 5.249

5.  Off-label intravenous thrombolysis in acute stroke.

Authors:  M Guillan; A Alonso-Canovas; J Garcia-Caldentey; V Sanchez-Gonzalez; I Hernandez-Medrano; A Defelipe-Mimbrera; M C Matute; M A Alonso-Arias; M Alonso de Leciñana; J Masjuan
Journal:  Eur J Neurol       Date:  2011-09-06       Impact factor: 6.089
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.